X T Xu
Index: Zhongguo Zhong Xi Yi Jie He Za Zhi 13(8) , 473-5, 453-4, (1993)
Full Text: HTML
In a preliminary study, carriers of hepatitis B virus were treated with Cinobufotalin, a preparation from toad, for 1-3 course of treatment. Results indicated that negative conversion rate was markedly higher in the treated groups (21.09%, 38.89%, 63.64% and 50%) than that of control groups (2.1%, 10.87%, 33.33% and 7.7% P < 0.001). By the end of treatment, positive conversion rate of anti-HBs and anti-HBe were also markedly higher in the former (19.29% and 23.45%) than that in the latter (4.26% and 7.14% P < 0.001). During the follow-up of 3-6 months, the positive rate of HBeAg in treated group (50%) raised as compared with the control group (20% P = 0.08). The results indicated that Cinobufotalin had a significant effect in inhibiting the replication of HBV.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cinobufotalin
CAS:1108-68-5 |
C26H34O7 |
Pre-clinical evaluation of cinobufotalin as a potential anti...
2014-09-26 [Biochem. Biophys. Res. Commun. 452(3) , 768-74, (2014)] |
Ceramide production mediates cinobufotalin-induced growth in...
2015-08-01 [Tumour Biol. 36 , 5763-71, (2015)] |
Comparative Analysis of the Bufonis Venenum by Using TLC, HP...
2012-12-01 [J Pharmacopuncture 15 , 52-65, (2015)] |
Chemical defense of an Asian snake reflects local availabili...
2013-04-01 [J. Zool. (Lond.) 289 , 270-278, (2013)] |
[Inhibitory effects of co-cinobufotalin oral liquor on hepat...
1996-12-01 [Zhongguo Zhong Xi Yi Jie He Za Zhi 16(12) , 738-40, (1996)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved